Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Cash from Financing Activities (2017 - 2020)

enVVeno Medical has reported Cash from Financing Activities over the past 4 years, most recently at $6.3 million for Q4 2020.

  • Quarterly results put Cash from Financing Activities at $6.3 million for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $15.1 million (up 167.43% YoY), and the annual figure for FY2025 was $1.0 million, down 92.5%.
  • Cash from Financing Activities for Q4 2020 was $6.3 million at enVVeno Medical, up from $5.9 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for NVNO hit a ceiling of $7.2 million in Q2 2018 and a floor of $570341.0 in Q1 2020.
  • Median Cash from Financing Activities over the past 4 years was $2.3 million (2019), compared with a mean of $3.2 million.
  • Biggest five-year swings in Cash from Financing Activities: grew 24.8% in 2019 and later crashed 75.39% in 2020.
  • enVVeno Medical's Cash from Financing Activities stood at $968352.0 in 2017, then soared by 640.88% to $7.2 million in 2018, then crashed by 53.73% to $3.3 million in 2019, then skyrocketed by 91.19% to $6.3 million in 2020.
  • The last three reported values for Cash from Financing Activities were $6.3 million (Q4 2020), $5.9 million (Q3 2020), and $2.3 million (Q2 2020) per Business Quant data.